364 related articles for article (PubMed ID: 17223016)
1. Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
Panagiotakopoulou A; Daikos GL; Miriagou V; Loli A; Tzelepi E; Tzouvelekis LS
Int J Antimicrob Agents; 2007 Mar; 29(3):360-2. PubMed ID: 17223016
[No Abstract] [Full Text] [Related]
2. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
Shah PM
Int J Antimicrob Agents; 2009 Oct; 34(4):381. PubMed ID: 19502012
[No Abstract] [Full Text] [Related]
3. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
[TBL] [Abstract][Full Text] [Related]
4. A VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
Weile J; Ohler S; Schönthal S; Knabbe C
Int J Antimicrob Agents; 2009 Apr; 33(4):389-91. PubMed ID: 19108993
[No Abstract] [Full Text] [Related]
5. Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
Hawser SP; Bouchillon SK; Hoban DJ; Hackel M; Johnson JL; Badal RE
Int J Antimicrob Agents; 2009 Oct; 34(4):384-5. PubMed ID: 19560904
[No Abstract] [Full Text] [Related]
6. Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
Poulou A; Spanakis N; Pournaras S; Pitiriga V; Ranellou K; Markou F; Tsakris A
J Antimicrob Chemother; 2010 Dec; 65(12):2538-42. PubMed ID: 20876622
[TBL] [Abstract][Full Text] [Related]
7. First identified case of VIM-producing carbapenem-resistant Klebsiella pneumoniae in the Republic of Ireland associated with fatal outcome.
Prior AR; Roche C; Lynch M; Kelly S; O'Rourke K; Crowley B
Euro Surveill; 2010 Dec; 15(50):. PubMed ID: 21172170
[No Abstract] [Full Text] [Related]
8. New Delhi metallo-β-lactamase and multidrug resistance: a global SOS?
Bonomo RA
Clin Infect Dis; 2011 Feb; 52(4):485-7. PubMed ID: 21258101
[No Abstract] [Full Text] [Related]
9. Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.
Webster DP; Gaulton T; Woodford N; Pike R; Turton J; Perry C; Bowler IC
Int J Antimicrob Agents; 2010 Dec; 36(6):575-6. PubMed ID: 20869852
[No Abstract] [Full Text] [Related]
10. Panresistance in VIM-1-producing Klebsiella pneumoniae.
Miriagou V; Tzelepi E; Daikos GL; Tassios PT; Tzouvelekis LS
J Antimicrob Chemother; 2005 May; 55(5):810-1. PubMed ID: 15772141
[No Abstract] [Full Text] [Related]
11. Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital.
Ktari S; Arlet G; Mnif B; Gautier V; Mahjoubi F; Ben Jmeaa M; Bouaziz M; Hammami A
Antimicrob Agents Chemother; 2006 Dec; 50(12):4198-201. PubMed ID: 17015633
[TBL] [Abstract][Full Text] [Related]
12. Plasmid-mediated carbapenem-hydrolysing β-lactamase KPC-2 in a Klebsiella pneumoniae isolate from Switzerland.
Poirel L; Lienhard R; Potron A; Malinverni R; Siegrist HH; Nordmann P
J Antimicrob Chemother; 2011 Mar; 66(3):675-6. PubMed ID: 21193473
[No Abstract] [Full Text] [Related]
13. Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase.
Naas T; Cuzon G; Babics A; Fortineau N; Boytchev I; Gayral F; Nordmann P
J Antimicrob Chemother; 2010 Jun; 65(6):1305-6. PubMed ID: 20382724
[No Abstract] [Full Text] [Related]
14. Isolation of a VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae isolate in Denmark.
Hasman H; Fjeldsøe-Nielsen H; Lausten T; Berthelsen BG
Int J Antimicrob Agents; 2010 Nov; 36(5):468-9. PubMed ID: 20724117
[No Abstract] [Full Text] [Related]
15. Resistance status and evolution trends of Klebsiella pneumoniae isolates in a university hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin.
Neonakis IK; Samonis G; Messaritakis H; Baritaki S; Georgiladakis A; Maraki S; Spandidos DA
Chemotherapy; 2010; 56(6):448-52. PubMed ID: 21088396
[TBL] [Abstract][Full Text] [Related]
16. Plasmid-mediated carbapenem-hydrolysing OXA-48 beta-lactamase in Klebsiella pneumoniae from Tunisia.
Cuzon G; Naas T; Lesenne A; Benhamou M; Nordmann P
Int J Antimicrob Agents; 2010 Jul; 36(1):91-3. PubMed ID: 20356714
[No Abstract] [Full Text] [Related]
17. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573
[TBL] [Abstract][Full Text] [Related]
18. Outbreaks in distinct regions due to a single Klebsiella pneumoniae clone carrying a bla VIM-1 metallo-{beta}-lactamase gene.
Ikonomidis A; Tokatlidou D; Kristo I; Sofianou D; Tsakris A; Mantzana P; Pournaras S; Maniatis AN
J Clin Microbiol; 2005 Oct; 43(10):5344-7. PubMed ID: 16208014
[TBL] [Abstract][Full Text] [Related]
19. Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone.
Cobo J; Morosini MI; Pintado V; Tato M; Samaranch N; Baquero F; Cantón R
Diagn Microbiol Infect Dis; 2008 Mar; 60(3):319-22. PubMed ID: 17996417
[TBL] [Abstract][Full Text] [Related]
20. Detection of GES-5-producing Klebsiella pneumoniae in Brazil.
Picão RC; Santos AF; Nicoletti AG; Furtado GH; Gales AC
J Antimicrob Chemother; 2010 Apr; 65(4):796-7. PubMed ID: 20139141
[No Abstract] [Full Text] [Related]
[Next] [New Search]
